Jeff Geschwind, MD: Cage Pharma Founder Jeff Geschwind, MD founded Cage Pharma, focusing on cancer metabolism drugs targeting glycolysis. His research paves the way for novel treatments against aggressive tumors. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/